Literature DB >> 21246839

[Pharmacological effects of Bailing capsule and its application in lung disease research].

Huijuan Xu1, Shiyue Li.   

Abstract

Cordyceps sinensis is a medicinal fungus of Traditional Chinese Medicine. There are a wide range of reported uses of Cordycep sinensis in the literature. However, the production of Cordyceps sinensis is so limited that can not be widely used. Cultured Cordyceps sinensis (Bailing Capsule) and natural Cordyceps sinensis have similar chemical composition. Bailing Capsule possesses anti-inflammatory, anti-hypoxia, anti-tumor effect function and regulating the endocrine system, enhanced immune function, which has a protective effect on the kidney, lung, liver and other organs. Recently, Bailing capsule has some beneficial effects on pulmonary diseases, such as COPD, Pulmonary fibrosis, Asthma, which have been gradually applied to the clinical.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21246839

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  6 in total

1.  Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China.

Authors:  Luca Richeldi; Adalberto Sperb Rubin; Sergey Avdeev; Zarir F Udwadia; Zuo Jun Xu
Journal:  BMC Med       Date:  2015-09-24       Impact factor: 8.775

Review 2.  A Systematic Review of the Mysterious Caterpillar Fungus Ophiocordyceps sinensis in Dong-ChongXiaCao ( Dōng Chóng Xià Cǎo) and Related Bioactive Ingredients.

Authors:  Hui-Chen Lo; Chienyan Hsieh; Fang-Yi Lin; Tai-Hao Hsu
Journal:  J Tradit Complement Med       Date:  2013-01

3.  Inhibitory effect of Bailing capsule on hypoxia-induced proliferation of rat pulmonary arterial smooth muscle cells.

Authors:  Xiahui Li; Kejun Peng; Yutian Zhou; Fengmei Deng; Jiao Ma
Journal:  Saudi Med J       Date:  2016-05       Impact factor: 1.484

4.  The Traditional Chinese Medicine Fufang Shatai Heji (STHJ) Enhances Immune Function in Cyclophosphamide-Treated Mice.

Authors:  Kai-Jian Fan; Yun-Wu Li; Jing Wu; Jun Li; Jun Zhang; Qi-Shan Wang; Bing-Xin Xu; Qing Cai; Ting-Yu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-23       Impact factor: 2.629

5.  Coronavirus disease 2019 (COVID-19) in a Chinese renal transplant recipient: a case report.

Authors:  Jian Wu; Liangkun Xiong; Peng Li
Journal:  Transl Androl Urol       Date:  2021-05

6.  Evaluation of the curative effects of Bailing capsules for treating chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.

Authors:  Long Zhang; Yumiao Zhao; Junli Jia; Lisha Huang; Weili Chu; Qinfu Xu; Yanbing Sheng; Aiguo Xu
Journal:  Medicine (Baltimore)       Date:  2021-06-25       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.